Should You Buy Aphria (TSX:APHA) on the Dip?

Aphria Inc (TSX:APHA)(NYSE:APHA) has been falling since the highs it reached earlier in the month, and that may have created a great buying opportunity for investors today.

August was looking like it would be a very good month for Aphria (TSX:APHA)(NYSE:APHA) after the stock soared on a good earnings report. However, since then, the stock has faltered, and it has dropped in value along with other cannabis stocks.

On Monday, Aphria’s stock closed at $8.45 — a big fall from the high of more than $10 a share that it reached earlier in the month. For investors, it could be a good opportunity to get back in at a lower price. After all, nothing has changed from the start of the month to the end that has drastically made Aphria a worse investment.

Valuation still looks decent

Aphria is not as overpriced as some of its peers, and with the decline in value, it might be a less risky investment overall. At around 1.2 times book value and nine times its sales, those are some modest multiples in an industry that’s been dominated by astronomical valuations.

One of the reasons for that, however, is that the stock has just not seen the same excitement that a stock like Canopy Growth has. Aphria has, unfortunately, provided investors with less-than-impressive returns, and that’s why it hasn’t had to come down a lot in price to be an appealing value today.

Why it’s a great opportunity to buy the stock

The company’s latest earnings report helped to re-establish Aphria as one of the top stocks in the industry. With strong sales growth and a profitable bottom line, it has attracted the attention of investors in a way that we haven’t seen in a while.

When also taking into consideration that recent struggles that Canopy Growth has faced, there could be a real opportunity for Aphria to move up the totem pole. While it would take a lot for investors to ditch Canopy Growth and buy Aphria instead, there’s going to be more of an appetite for that than there may have been in the past. Especially with poor earnings and a whole lot of uncertainty weighing Canopy Growth down as of late.

Pot stocks normally move together, as the general outlook for the industry can play a big role in whether stocks like Aphria or Canopy Growth rise in value. Even if the companies are doing well, if investors are concerned about the outlook for marijuana, it may not matter. Currently, we’re in a down cycle, but once things pick up again, perhaps as edibles get closer to launching, we could see another wave, which could send Aphria stock back up over $10.

Bottom line

Even though Aphria stock rallied earlier in the month, its share price has still taken a beating this year, as it’s down around 36% year to date. However, with the strong earnings and the stock generally seeing strong support at around $8 a share, it could prove to be a safe bet at its current price. While there’s always a risk that it could go lower, it seems unlikely to do so given the positivity around the stock today.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »